The programmed cell death 1 (PD-1) signaling pathway, a key player in immune checkpoint
regulation, has become a focal point in cancer immunotherapy. In the context of cancer …

The landscape of diagnosing and treating endometrial cancer is undergoing a profound
transformation due to the integration of molecular analysis and innovative therapeutic …

Introduction Eosinophilic esophagitis (EoE) is a chronic, inflammatory, antigen-driven
disease of the esophagus. Tissue EoE pathology has previously been extensively …

Checkpoint inhibitors are monoclonal antibodies that elicit an anti-tumor response by
stimulating immune system. Their use has improved the treatment of different types of cancer …

Simple Summary We have recently witnessed several milestones in the treatment of various
cancers with immunotherapy through modulating the activity of the immune system to …

Extraparenchymal neurocysticercosis (EP-NC) is a chronic, potentially life-threatening
disease that responds poorly to initial anthelmintic drug therapy. A depressed specific …

Co-inhibitory receptors (Co-IRs) are essential in controlling the progression of
immunopathology in rheumatoid arthritis (RA) by limiting T cell activation. The objective of …

CD4+ CD25+ Foxp3+ regulatory T cells (Tregs), a vital component of the immune system,
are responsible for maintaining immune homeostasis and preventing excessive immune …

Primary cutaneous lymphomas (PCLs) are a heterogeneous group of lymphoproliferative
disorders caused by the accumulation of neoplastic T or B lymphocytes in the skin. Sézary …

Disseminated adenovirus infection is a complication with a relatively high mortality rate
among patients undergoing hematopoietic stem cell transplantation. The low efficacy and …